By expenditures
| Name | Title | Type |
|---|---|---|
| Lisa Benfield | Chief Financial Officer | Auditee |
| Andrew Dobson | Shareholder | Auditee |
| Allison Poole | DEPUTY FINANCE DIRECTOR | Auditee |
| Andrew Coleman | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 377771 | 2025 | 2025-12-29 | GREENE FINNEY CAULEY LLP | $43.88M |
| 334667 | 2024 | 2024-12-23 | Greene Finney Cauley LLP | $17.91M |
| 299764 | 2023 | 2024-03-28 | Greene Finney Cauley LLP | $7.17M |
| 27681 | 2022 | 2023-03-01 | Halliday Schwartz & CO | $16.98M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 377771 | 2025 | 2025-12-29 | 1166702 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166701 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166700 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166699 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166698 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166697 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166696 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166695 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166694 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166693 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166692 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166691 | 2025-001 | Material Weakness | Yes | B |
| 377771 | 2025 | 2025-12-29 | 1166690 | 2025-001 | Material Weakness | Yes | B |
| 299764 | 2023 | 2024-03-28 | 964143 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 964142 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 964141 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 964140 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 964139 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 964138 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 964137 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 964136 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 964135 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 964134 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 387701 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 387700 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 387699 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 387698 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 387697 | 2023-004 | Significant Deficiency | - | H |
| 299764 | 2023 | 2024-03-28 | 387696 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 387695 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 387694 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 387693 | 2023-003 | Significant Deficiency | - | B |
| 299764 | 2023 | 2024-03-28 | 387692 | 2023-003 | Significant Deficiency | - | B |
| 27681 | 2022 | 2023-03-01 | 605074 | 2022-001 | Significant Deficiency | - | L |
| 27681 | 2022 | 2023-03-01 | 605073 | 2022-001 | Significant Deficiency | - | L |
| 27681 | 2022 | 2023-03-01 | 28632 | 2022-001 | Significant Deficiency | - | L |
| 27681 | 2022 | 2023-03-01 | 28631 | 2022-001 | Significant Deficiency | - | L |